Pistacia Pharmaceuticals Private Limited, a active private limited company, was established on 17 February 2020 in Vartak Nagar, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999MH2020PTC337812. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Kamlesh Mathur (Additional Director), Dileep Mathur (Additional Director), Anita Singh (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat-301, Anand Building, Kores Tower A-1,, Vartak Nagar,, Maharashtra, 400606.
U74999MH2020PTC337812
337812
17 February 2020
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Pistacia Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamlesh Mathur | Additional Director | 05 Jun 2020 | Current |
| Dileep Mathur | Additional Director | 03 Oct 2020 | Current |
| Anita Singh | Director | 17 Feb 2020 | Current |
| Sneh Lata | Director | 17 Feb 2020 | Current |
| Neetu Bala | Director | 17 Feb 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pistacia Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1033.45% increase. The company also saw a substantial improvement in profitability, with a 66.49% increase in profit. The company's net worth observed a substantial decline by a decrease of 42.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Pistacia Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Pistacia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pistacia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pistacia Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Pistacia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Pistacia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Dileep Mathur was appointed as a Additional Director was appointed as a Additional Director on 03 Oct 2020 & has been associated with this company since 5 years 2 months . was recorded as a recent event.
Progress on Kamlesh Mathur was appointed as a Additional Director was appointed as a Additional Director on 05 Jun 2020 & has been associated with this company since 5 years 6 months . was documented.
Anita Singh was appointed as a Director was appointed as a Director on 17 Feb 2020 & has been associated with this company since 5 years 9 months . was recorded as a recent event.
Progress on Sneh Lata was appointed as a Director was appointed as a Director on 17 Feb 2020 & has been associated with this company since 5 years 9 months . was documented.
The CIN of Pistacia Pharmaceuticals Private Limited is U74999MH2020PTC337812.
Pistacia Pharmaceuticals Private Limited is headquartered at Flat-301, Anand Building, Kores Tower A-1,, Vartak Nagar,, Maharashtra, 400606.
Pistacia Pharmaceuticals Private Limited was incorporated on 17 February 2020.
The current directors of Pistacia Pharmaceuticals Private Limited are
The primary industry of Pistacia Pharmaceuticals Private Limited is Trade.
Pistacia Pharmaceuticals Private Limited is unlisted.
The authorized capital of Pistacia Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX